| Nadine Marie Yvanne Louissaint, NP | |
|
1101 W Broward Blvd, Fort Lauderdale, FL 33312-1638 | |
| (954) 527-6041 | |
| (954) 527-6052 |
| Full Name | Nadine Marie Yvanne Louissaint |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1101 W Broward Blvd, Fort Lauderdale, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043727621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN9313086 (Florida) | Primary |
| Entity Name | North Broward Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801581129 PECOS PAC ID: 3577472422 Enrollment ID: O20040405001860 |
News Archive
The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) have joined 17 other surgical organizations in opposing the "Patient Protection and Affordable Care Act" introduced by Senate Majority Leader Harry Reid.
Cytori Therapeutics, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies & Company, Inc. is acting as sole book-running manager for the offering.
On Wednesday Revalesio Corporation presented new data at the Alzheimer's Association International Conference that identifies the specific cellular pathways by which Revalesio's lead investigational product, RNS60, impacts Alzheimer's Disease. This research, conducted in partnership with Rush University Medical Center, investigates a new category of therapeutics using Revalesio's novel nanotechnology platform.
According to new research from the U.S., as people get older communication between different regions of the brain breaks down.
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nadine Marie Yvanne Louissaint, NP 1700 Nw 49th St Ste 125, Fort Lauderdale, FL 33309-3750 Ph: (954) 527-6041 | Nadine Marie Yvanne Louissaint, NP 1101 W Broward Blvd, Fort Lauderdale, FL 33312-1638 Ph: (954) 527-6041 |
News Archive
The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) have joined 17 other surgical organizations in opposing the "Patient Protection and Affordable Care Act" introduced by Senate Majority Leader Harry Reid.
Cytori Therapeutics, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies & Company, Inc. is acting as sole book-running manager for the offering.
On Wednesday Revalesio Corporation presented new data at the Alzheimer's Association International Conference that identifies the specific cellular pathways by which Revalesio's lead investigational product, RNS60, impacts Alzheimer's Disease. This research, conducted in partnership with Rush University Medical Center, investigates a new category of therapeutics using Revalesio's novel nanotechnology platform.
According to new research from the U.S., as people get older communication between different regions of the brain breaks down.
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
› Verified 7 days ago
Jessica Francois, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 900 Nw 31st Ave, Fort Lauderdale, FL 33311 Phone: 954-467-4700 | |
Nicole K Rodolpho, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6000 N Federal Hwy, Fort Lauderdale, FL 33308 Phone: 954-771-2551 Fax: 954-492-3830 | |
Mrs. Stacy Ann Krause, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4725 N Federal Hwy, Fort Lauderdale, FL 33308 Phone: 954-771-8000 | |
Melissa Shaffer, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4943 N Harbor Isles Dr, Fort Lauderdale, FL 33312 Phone: 954-625-5966 | |
Mrs. Holly Hirnyk, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4725 N Federal Hwy, Fort Lauderdale, FL 33308 Phone: 614-679-7841 | |
Kelly Melissa Roland, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1601 S Andrews Ave Fl 3, Fort Lauderdale, FL 33316 Phone: 954-763-6655 Fax: 954-763-6799 | |
Mrs. Sara Jayne Levene, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2708 E Oakland Park Blvd, Fort Lauderdale, FL 33306 Phone: 954-318-0873 |